Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 10, 2016 6:16 AM ET

Healthcare Equipment and Supplies

Company Overview of eNeura Inc.

Company Overview

eNeura Inc., a medical technology company, provides portable non-invasive transcranial magnetic stimulation devices for the treatment of migraine. The company offers Transcranial Magnetic Stimulation (TMS)/SpringTMS, a transcranial magnetic stimulation device for the acute treatment of pain associated with migraine headache with aura. Its SpringTMS utilizes single-pulse TMS to induce mild electrical currents that depolarize neurons in the brain. The company serves patients in the United States and the United Kingdom. eNeura Inc. was formerly known as eNeura Therapeutics LLC and changed its name to eNeura Inc. in February 2014. The company was incorporated in 2012 and is based in Baltimore, M...

801 West Baltimore Street

Suite 502 L

Baltimore, MD 21201

United States

Founded in 2012





Key Executives for eNeura Inc.

Chief Executive Officer, President and Director
Age: 56
Founder and Director
Age: 86
Chief Financial Officer
Age: 64
Vice President of Marketing
Compensation as of Fiscal Year 2015.

eNeura Inc. Key Developments

eNeura, Inc. Receives FDA Clearance for SpringTMS(R) Migraine Treatment Device

eNeura Inc. announced that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its SpringTMS(R) migraine treatment device. SpringTMS is the first medical device available to patients in the United States for the acute treatment of pain associated with migraine headache with aura. SpringTMS is a prescription-only device that utilizes single-pulse Transcranial Magnetic Stimulation (sTMS) to induce very mild electrical currents that can depolarize neurons in the brain. This process is thought to interrupt the abnormal hyperactivity associated with migraine. The non-invasive, proprietary device is designed for patient use. To treat, the device is placed at the back of the head where the push of a button generates a focused magnetic pulse with the intent to eliminate the pain of a migraine headache. SpringTMS provides the same therapy as the Cerena device but offers improved portability. The initial U.S. availability of SpringTMS will be launched at a select number of U.S. specialist headache centers.

Similar Private Companies By Industry

Company Name Region
MedShape, Inc. United States
BluDiagnostics, Inc. United States
OrthogenRx, Inc. United States
Micropace EP Inc. United States
Merits Health Products, Inc. United States

Recent Private Companies Transactions

Private Placement
March 4, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact eNeura Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at